title: Interaction of tau protein with model lipid membranes induces tau structural compaction and membrane disruption.
abstract: The misfolding and aggregation of the intrinsically disordered, microtubule-associated tau protein into neurofibrillary tangles is implicated in the pathogenesis of Alzheimer's disease. However, the mechanisms of tau aggregation and toxicity remain unknown. Recent work has shown that anionic lipid membranes can induce tau aggregation and that membrane permeabilization may serve as a pathway by which protein aggregates exert toxicity, suggesting that the plasma membrane may play dual roles in tau pathology. This prompted our investigation to assess tau's propensity to interact with membranes and to elucidate the mutually disruptive structural perturbations the interactions induce in both tau and the membrane. We show that although highly charged and soluble, the full-length tau (hTau40) is also highly surface active, selectively inserts into anionic DMPG lipid monolayers and induces membrane morphological changes. To resolve molecular-scale structural details of hTau40 associated with lipid membranes, X-ray and neutron scattering techniques are utilized. X-ray reflectivity indicates hTau40s presence underneath a DMPG monolayer and penetration into the lipid headgroups and tailgroups, whereas grazing incidence X-ray diffraction shows that hTau40 insertion disrupts lipid packing. Moreover, both air/water and DMPG lipid membrane interfaces induce the disordered hTau40 to partially adopt a more compact conformation with density similar to that of a folded protein. Neutron reflectivity shows that tau completely disrupts supported DMPG bilayers while leaving the neutral DPPC bilayer intact. Our results show that hTau40s strong interaction with anionic lipids induces tau structural compaction and membrane disruption, suggesting possible membrane-based mechanisms of tau aggregation and toxicity in neurodegenerative diseases.
authors.affiliation: Department of Chemical and Nuclear Engineering, Center for Biomedical Engineering, University of New Mexico, Albuquerque, New Mexico 87131, United States.
authors.forename: Emmalee M
authors.initials: EM
authors.lastname: Jones
authors.forename: Manish
authors.initials: M
authors.lastname: Dubey
authors.forename: Phillip J
authors.initials: PJ
authors.lastname: Camp
authors.forename: Briana C
authors.initials: BC
authors.lastname: Vernon
authors.forename: Jacek
authors.initials: J
authors.lastname: Biernat
authors.forename: Eckhard
authors.initials: E
authors.lastname: Mandelkow
authors.forename: Jaroslaw
authors.initials: J
authors.lastname: Majewski
authors.forename: Eva Y
authors.initials: EY
authors.lastname: Chi
mesh_terms: D002462:Cell Membrane / Q000737:chemistry* / Q000378:metabolism*; D006801:Humans; D008051:Lipid Bilayers / Q000737:chemistry* / Q000378:metabolism*; D033363:Neutron Diffraction; D011485:Protein Binding; D011487:Protein Conformation; D012995:Solubility; D014961:X-Ray Diffraction; D016875:tau Proteins / Q000737:chemistry* / Q000378:metabolism*
chemical_list: D008051:Lipid Bilayers; D016875:tau Proteins